Skip to main navigation

Back

Contact Revance
Login

Menu

Aesthetics
Back Aesthetics
Visit Site
Therapeutics
Back Therapeutics
Investors
Back Investors
LATEST NEWS
Our Latest

December 22, 2020

Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection All News
Company
Back Company
OUR LATEST
Our Latest

December 22, 2020

Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection Our Latest
News
Careers
Back Careers

facebook
instagram
twitter
linkedin

1222 Demonbreun St
Suite 2000
Nashville, TN 37203

+1 (510) 742-3400

Contact Revance
Login

© Copyright 2021

All Rights Reserved

Breadcrumb

Home
Investors
Press releases

Press Releases

Press Releases

Items Per Page

Year

December 14, 2015

Revance Appoints Abhay Joshi, PhD, as Chief Operating Officer

November 19, 2015

Revance Therapeutics to Participate in the 27th Annual Piper Jaffray Healthcare Conference

November 9, 2015

Revance Therapeutics Releases Third Quarter 2015 Results

November 9, 2015

Revance Therapeutics Announces Closing of Public Offering of Common Stock

November 4, 2015

Revance Therapeutics to Present at Credit Suisse 24th Annual Healthcare Conference

November 4, 2015

Revance Therapeutics to Release Third Quarter 2015 Financial Results Monday, November 9, 2015

November 4, 2015

Revance Therapeutics Announces Pricing of Public Offering of Common Stock

November 2, 2015

Revance Therapeutics Announces Proposed Public Offering of Common Stock

October 29, 2015

Revance Reports Positive 6-Month Duration in BELMONT Study

September 29, 2015

Revance Therapeutics Initiates Phase 2 Clinical Study of Its Unique Botulinum Toxin Type A for Injection to Treat Cervical Dystonia

Pagination

First page
Previous page
…
Page 15
Page 16
Page 17
Page 18
Current page 19
Page 20
Page 21
Page 22
Page 23
…
Next page
Last page

Displaying 181 - 190 of 242

Investor Relations

Investor Relations
Press Releases
Events & Webcasts
- Presentations and Corporate Materials
- Video Library
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQs
Contact Us

image description

Revance - Shareholder Tools

Print Page
Printed Materials
Email Alerts
Download Library
RSS News Feeds
Share
Search

Keep up with Revance

Subscribe

1222 Demonbreun St
Suite 2000
Nashville, TN 37203

+1 (510) 742-3400

facebook
instagram
twitter
linkedin

Aesthetics

Overview
RHA®
HintMD
Neuromodulator
Neuromodulator Uses
Clinical Highlights

Therapeutics

Overview
Cervical Dystonia
Upper Limb Spasticity
Plantar Fasciitis
Clinical Highlights

Investors

Investor Relations
Press Releases
Events & Webcasts
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQ

Company

Overview
About Revance
Leadership Team
Board of Directors
Partnerships
Investigator Sponsored Trials
Medical Education Grants
Sustainability
Contact Revance

News

All News
In the News
Our Latest

Careers

Overview
Career Opportunities
Culture
Benefits & Perks

© Copyright 2021
All Rights Reserved
Terms of Use
Privacy Policy
Corporate Social Media Community Guidelines

Facebook
LinkedIn